Studies that collect data prospectively and are deemed to be of minimal risk over standard procedures are considered ‘delegated prospective’ studies. These studies are reviewed by a subset of the Board and are submitted to the Research Ethics Board (REB) through the delegated prospective application process.
Studies that qualify for delegated review as minimal risk research may include:
Delegated prospective applications are accepted on a rolling basis and not subject to a submission deadline.
Please follow these instructions to submit a delegated prospective application to the REB:
Log into the Unity Health eREB to complete and submit an application. For information on creating an account and logging in, please see the eREB page.
The following documents (if applicable) will be required with your submission:
Once your application is complete, the eREB will prompt you to obtain PI and Co-I signatures. Once the last investigator has signed, the application will be submitted to the REB.
If you have any questions, please contact your Research Ethics Coordinator. Your Research Ethics Coordinator will be identified in your review letter and will be the point of contact between you and the Board and will work with you through the review and approval process.
If you don’t have a Research Ethics Coordinator, please email researchethics@smh.ca.
Once the review is complete and all concerns have been addressed, your application will be approved for a maximum of one year, and your approval letter will be sent to you via email.
Note: This approval pertains only to the research ethics components of your study. Please ensure that all other institutional approvals and contracts have been established prior to beginning your research.
As your study progresses, make sure to keep the REB informed of any amendments, changes, or annual renewals to your study. In addition, please ensure your annual renewals are submitted prior to the expiry of your current approval.
